Similarities and differences in asthma and COPD: The Dutch hypothesis

Chest

Volumn 126, Issue 2 SUPPL., 2004, Pages 93S-95S

  Bleecker, Eugene R ^a,b  

^a WAKE FOREST UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHUS HYPERREACTIVITY; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE COURSE; EMPHYSEMA; FORCED EXPIRATORY VOLUME; HEALTH SURVEY; HUMAN; LONG TERM CARE; MORBIDITY; MORPHOLOGICAL TRAIT; MORTALITY; PREVALENCE; PRIORITY JOURNAL; SHORT COURSE THERAPY; SHORT SURVEY; SMOKING;

EID: 4143109103     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.2_suppl_1.93S     Document Type: Article

References (16)

1. National Heart, Lung, and Blood Institute. Morbidity and mortality: 2000 chartbook on cardiovascular, lung, and blood diseases. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health, 2000
2. National Center for Health Statistics. Vital health statistics: plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Atlanta, GA: Centers for Disease Control and Prevention, 1994; 1-406
3. Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160:1683-1689
4. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO workshop report executive summary. Bethesda, MD: National Institutes of Health, 2001; NIH Publication No. 2701
5. Global Initiative for Asthma. Global strategy for asthma management and prevention. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health, 2002; NIH Publication No. 02-3659
6. Mannino DM, Brown C, Giovino GA. Obstructive lung disease deaths in the United States from 1979 through 1993: an analysis using multiple-cause mortality data. Am J Respir Crit Care Med 1997; 156:814-818
7. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002; 121(suppl):121S-126S
8. American Thoracic Society. Chronic bronchitis, asthma, and pulmonary emphysema: a statement by the Committee on Diagnostic Standards for Nontuberculous Respiratory Diseases. Am Rev Respir Dis 1962; 85:762-768
9. Burrows B, Bloom JW, Traver GA, et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987; 317:1309-1314
10. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:877-8121
11. Mahler DA, Donohue JF, Barbee RA, et al. Efficacy of salmeterol xinafoate in the treatment of COPD. Chest 1999; 115:957-965
12. Donohue JF, van Noord JA, Bateman ED, et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002; 122:47-55
13. National Asthma Education and Prevention Program. Expert panel report 2: guidelines for the diagnosis and management of asthma. Bethesda MD: National Institutes of Health, 1997; NIH Publication No. 97-4051
14. Kerstjens HAM, Brand PLP, Hughes MD, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease: the Dutch Chronic Non-Specific Lung Disease Study Group. N Engl J Med 1992; 327:1413-1419
15. Orie NGM, Sluiter HJ, de Vries K, et al. The host factor in bronchitis. In: Orie NGM, Sluiter HJ, eds. Bronchitis. Assen, the Netherlands: Royal van Gorcum, 1961; 43-59
16. Silverman EK, Palmer LJ, Mosley JD, et al. Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet 2002; 70:1229-1239